These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 480917)

  • 1. Erythema multiforme bullosum due to rifampicin.
    Nigam P; Dayal SG; Goyal BM
    Lepr India; 1979 Apr; 51(2):249-51. PubMed ID: 480917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythema multiforme bullosum due to dapsone.
    Dutta RK
    Lepr India; 1980 Apr; 52(2):306-9. PubMed ID: 7453143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver and kidney damage in rifampicin and ethambutol treatment].
    Kozma D; Mihalik P
    Z Erkr Atmungsorgane; 1984; 162(3):249-55. PubMed ID: 6485386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic effect of Rifampicin on re-treatment cases of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):227-35. PubMed ID: 5449510
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 14. Worsening of steroid dependent asthma : A possible role of rifampicin.
    Gupta D; Yadav S; Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):35-8. PubMed ID: 16892737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient.
    Kar HK; Roy RG
    Indian J Lepr; 1984; 56(4):835-9. PubMed ID: 6549453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
    Gyselen A; Cosemans J; Lacquet L; Verbist L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):128-35. PubMed ID: 4491709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.